State of Wyoming’s Regeneron Pharmaceuticals REGN Stock Holding History

State of Wyoming’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$74.2K	Buy	+119	New	+$81K	0.01%	1522
2025 Q4	–	Sell	-243	Closed	-$137K	–	2050
2025 Q3	$137K	Buy	+243	New	+$137K	0.02%	1156
2022 Q3	–	Sell	-142	Closed	-$84K	–	1864
2022 Q2	$84K	Sell	142 -211	-60%	-$137K	0.05%	617
2022 Q1	$247K	Buy	353 +68	+24%	+$43K	0.12%	122
2021 Q4	$180K	Buy	285 +35	+14%	+$21.5K	0.08%	268
2021 Q3	$151K	Buy	250 +99	+66%	+$61.5K	0.1%	259
2021 Q2	$84K	Sell	151 -114	-43%	-$57.8K	0.05%	532
2021 Q1	$125K	Buy	+265	New	+$129K	0.21%	88

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State of Wyoming's REGN Position: Q2 2026 in Review

State of Wyoming opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 119 shares worth $74.2K. The stake represents 0.01% of the portfolio and ranks #1522 among its holdings. This is a return to the name: State of Wyoming previously reported a position in REGN as recently as Q3 2025.

State of Wyoming first reported a position in REGN in Q1 2021 and has held it in 8 quarters since. The position peaked at $247K in Q1 2022. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

State of Wyoming held 119 shares of Regeneron Pharmaceuticals worth $74.2K as of Q2 2026.
Regeneron Pharmaceuticals was a new State of Wyoming position in Q2 2026.
Regeneron Pharmaceuticals made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1522 holding.
State of Wyoming first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
State of Wyoming's Regeneron Pharmaceuticals position peaked at $247K in Q1 2022.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.